'Taking Ozempic doesn’t help us to work on our societal prejudice against obesity and the scrutiny of a person’s looks. Fatness itself isn’t the problem—we are,' shares writer Raven Smith.
. The weekly injection offers the seemingly impossible: making and keeping you thin. You don’t have to be careful or eat clean or even mindfully—you just jab and go. It’s not unlike other drugs that have started out medicinal before turning recreational.
We’ll all enthralled, enjoying the hype, the who’s-on-it sleuth-ery of Ozempic. I too am guilty of zooming in on selfies, Poirot-ing for signs of meds-induced shrinkage. We’re absorbing theBut then there’s the insidious ideology that this latest weight-loss drug pushes. Societaland un-slimness abound: Anyone bigger than you eats more than you, moves less that you, can’t control themselves. We ignore the correlation between obesity and wealth—the time and money it takes to dodge processed foods.
I know I’m being glib, but in recent times we’ve watched the conversation around bodies change for the better, for the more understanding, for the more realistic…and now we’re all, erm, excited to fix the problem ASAP? A problem we all agreed wasn’t a problem? We’ve yo-yoed our progression. I guess, depressingly, that the power of thin hasn’t waned. I hate the idea, pushed by this jab, that your best self is thinner, leaner, than your current self. I hate the idea that fat is fine for
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Why Weight Watchers is buying a company that prescribes popular weight-loss drugs like OzempicIt's the latest example how a new class of therapies has revolutionized the way many Americans think about weight loss.
Weiterlesen »
WeightWatchers prescription med move causes concern for those who need Ozempic for type 2 diabetesWeightWatchers shares soared after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Weiterlesen »
WeightWatchers buys telehealth platform Sequence, facilitating access to Ozempic and WegovyThe diet company is hoping to offer members the ability to meet with clinicians who can prescribe obesity and diabetes medications.
Weiterlesen »
WeightWatchers Is Getting In on the Ozempic BoomThe company acquired telehealth provider Sequence, which prescribes weight-loss drugs, for $106 million.
Weiterlesen »
WeightWatchers prescription med move causes concern for those who need Ozempic for type 2 diabetesWeightWatchers shares soared after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Weiterlesen »
WeightWatchers prescription med move causes concern for those who need Ozempic for type 2 diabetesWeightWatchers shares soared after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Weiterlesen »